{"id":"https://openalex.org/W2806557019","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.1010","title":"Determinants of high tumor mutational burden (TMB) and mutational signatures in breast cancer.","display_name":"Determinants of high tumor mutational burden (TMB) and mutational signatures in breast cancer.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2806557019","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.1010","mag":"2806557019"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.1010","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.1010","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.1010","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071273328","display_name":"Romualdo Barroso\u2010Sousa","orcid":"https://orcid.org/0000-0002-1825-9876","observed_orcids":["https://orcid.org/0000-0002-1825-9876"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Romualdo Barroso-Sousa","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010075419","display_name":"Esha Jain","orcid":"https://orcid.org/0000-0003-1201-2052","observed_orcids":["https://orcid.org/0000-0003-1201-2052"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Esha Jain","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA;","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088232181","display_name":"Dewey Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dewey Kim","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA;","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039694693","display_name":"Ann H. Partridge","orcid":"https://orcid.org/0000-0002-4722-4824","observed_orcids":["https://orcid.org/0000-0002-4722-4824"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann H. Partridge","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083324690","display_name":"Ofir Cohen","orcid":"https://orcid.org/0000-0002-0043-6838","observed_orcids":["https://orcid.org/0000-0002-0043-6838"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ofir Cohen","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA;","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068721624","display_name":"Nikhil Wagle","orcid":"https://orcid.org/0000-0003-3332-9438","observed_orcids":["https://orcid.org/0000-0003-3332-9438"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil Wagle","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"1010","last_page":"1010"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.7484999895095825,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.7484999895095825,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.20499999821186066,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.013899999670684338,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.9279999732971191},{"id":"https://openalex.org/keywords/mutational-signatures","display_name":"mutational signatures","score":0.9639999866485596},{"id":"https://openalex.org/keywords/apobec-signature","display_name":"APOBEC signature","score":0.9319999814033508},{"id":"https://openalex.org/keywords/mismatch-repair-deficiency","display_name":"mismatch repair deficiency","score":0.7549999952316284},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9490000009536743},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9089999794960022},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.7860000133514404},{"id":"https://openalex.org/keywords/breast-cancer-histopathology","display_name":"breast cancer histopathology","score":0.6299999952316284},{"id":"https://openalex.org/keywords/breast-cancer-subtypes","display_name":"breast cancer subtypes","score":0.5979999899864197},{"id":"https://openalex.org/keywords/immunotherapy-response","display_name":"immunotherapy response","score":0.6309999823570251},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.8939999938011169},{"id":"https://openalex.org/keywords/tumor-genomic-profiling","display_name":"tumor genomic profiling","score":0.46299999952316284},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.49000000953674316},{"id":"https://openalex.org/keywords/pik3ca","display_name":"PIK3CA","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C2776162770","wikidata":"https://www.wikidata.org/wiki/Q4653351","display_name":"APOBEC","level":4,"score":0.8355734348297119},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7288039326667786},{"id":"https://openalex.org/C128526571","wikidata":"https://www.wikidata.org/wiki/Q619302","display_name":"Somatic hypermutation","level":4,"score":0.7176720499992371},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6902127265930176},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5804140567779541},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4861604869365692},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.47730767726898193},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4628773033618927},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.42523667216300964},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41436392068862915},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16683530807495117},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.10646611452102661},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.0},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.0},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.1010","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.1010","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.1010","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3000078203","https://openalex.org/W4413051556","https://openalex.org/W3168113744","https://openalex.org/W4322774265","https://openalex.org/W2947876098","https://openalex.org/W4322770130","https://openalex.org/W2985618399","https://openalex.org/W4379328514","https://openalex.org/W3132002767","https://openalex.org/W4407122589"],"abstract_inverted_index":{"1010":[0],"Background:":[1],"High":[2],"TMB":[3,90,111,115,203,277],"correlates":[4],"with":[5,208,216,243,259,270,280],"high":[6,89,246],"neoantigen":[7],"burden,":[8],"and":[9,31,55,145,152,197,210,218,223,287,305,325],"this":[10,23,297],"is":[11,25,278,323],"thought":[12],"to":[13,18,26,77,119,317],"be":[14],"predictive":[15],"of":[16,22,34,147,162,176,183,256,267,289,310],"response":[17],"immunotherapy.":[19],"The":[20,71,109,307],"aim":[21],"work":[24],"evaluate":[27,78],"frequency,":[28],"mutational":[29,79,292],"patterns,":[30],"genomic":[32],"profile":[33],"hypermutated":[35,165,178,228,257,268,320],"breast":[36,82,321],"cancer.":[37],"Methods:":[38],"We":[39,102,158],"used":[40],"sequencing":[41],"data":[42],"from":[43],"publically":[44],"available":[45],"on":[46],"cbioportal.org,":[47],"including":[48,283,299],"TCGA,":[49],"France":[50],"2016,":[51],"MSK-IMPACT,":[52],"MBCProject,":[53],"AACR-GENIE,":[54],"ongoing":[56],"studies":[57],"at":[58],"our":[59],"institute":[60],"(The":[61],"Center":[62],"for":[63,106,206],"Cancer":[64,69,75],"Precision":[65],"Medicine":[66],"Metastatic":[67],"Breast":[68,74],"Study;":[70],"Young":[72],"Women\u2019s":[73],"Study)":[76],"load":[80],"across":[81],"cancers.":[83],"Samples":[84],"were":[85],"classified":[86],"as":[87],"having":[88],"if":[91],"they":[92],"had":[93,232,247,262],">":[94,122,130,132,134,141],"10":[95],"mutations":[96,264],"(mut)":[97],"per":[98],"megabase":[99],"(MB).":[100],"Results:":[101],"included":[103],"3689":[104],"samples":[105,179,207,231],"the":[107,177,181,236,241],"analysis.":[108],"median":[110],"was":[112,204],"1.55":[113],"mut/MB.":[114],"significantly":[116],"varied":[117],"according":[118],"histology":[120],"(ductal":[121],"lobular,":[123],"p=":[124,143],"4.6x10-13),":[125],"tumor":[126],"subtype":[127,286],"(HR-/":[128],"HER2+":[129],"TNBC":[131],"HR+/HER2+":[133],"HR+/HER2-,":[135],"p":[136,155],"<":[137,156],"0.05),":[138],"staging":[139],"(metastatic":[140],"primary,":[142],"2.2x10-16)":[144],"site":[146,288],"metastasis":[148],"(higher":[149],"soft":[150],"tissue,":[151],"lowest":[153],"lung,":[154],"0.05).":[157],"found":[159],"a":[160,248],"total":[161],"70":[163],"(~2%)":[164],"tumors":[166,258,269],"(62.8%":[167],"metastatic":[168],"vs":[169],"37.2%":[170],"primary":[171],"samples).":[172],"Mutational":[173],"signature":[174,245,261],"analysis":[175],"showed":[180],"presence":[182],"dominant":[184],"APOBEC":[185,219,260],"(77.1%),":[186],"homologous":[187],"recombination":[188],"(HR;":[189],"2.9%),":[190],"defective":[191,301],"DNA":[192,302],"mismatch":[193],"repair":[194],"(MMR;":[195],"18.6%),":[196],"POLE":[198,209,237,244,250],"hypermutation":[199],"(1.4%)":[200],"signatures.":[201],"Median":[202],"higher":[205],"HR":[211,304],"signature,":[212],"followed":[213],"by":[214],"those":[215],"MMR":[217],"(93.1,":[220],"38.7,":[221],"14.6":[222],"12.4":[224],"mut/MB,":[225],"respectively).":[226],"Among":[227],"tumors,":[229],"8":[230],"somatic":[233],"mutation":[234],"in":[235,296,314,319],"gene,":[238],"but":[239],"only":[240],"case":[242],"characterized":[249],"driver":[251],"mutation.":[252],"In":[253],"addition,":[254],"80%":[255],"PIK3CA":[263],"versus":[265],"31%":[266],"other":[271],"signatures":[272,293,313],"(p":[273],"=":[274],"0.0005).":[275],"Conclusions:":[276],"correlated":[279],"clinical":[281],"parameters":[282],"histology,":[284],"receptor":[285],"metastasis.":[290],"Different":[291],"are":[294],"present":[295],"population,":[298],"POLE,":[300],"MMR,":[303],"APOBEC.":[306],"potential":[308],"role":[309],"these":[311],"different":[312],"predicting":[315],"benefit":[316],"immunotherapy":[318],"cancers":[322],"unclear,":[324],"warrants":[326],"further":[327],"investigation.":[328]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":5}],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2018-06-13T00:00:00"}